Physician profile
Tracey Shaffer
NPI 1598137564
$13,180.67
in general payments reported to CMS, 2019-2025
30 companies · $3,068 in 2025
The $3,068 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,489 · 2022: $2,115 · 2023: $2,672 · 2024: $3,836 · 2025: $3,068.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,949 · Education: $878 · Consulting Fee: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,948.53 |
| Education | $878.21 |
| Consulting Fee | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,890.73 | 2021-2025 | Tremfya, Remicade, Simponi |
| Arcutis Biotherapeutics, INC. | $1,408.32 | 2023-2025 | Zoryve |
| Abbvie INC. | $1,402.42 | 2021-2025 | |
| Amgen INC. | $1,343.63 | 2021-2025 | Otezla, Otezla |
| Incyte Corporation | $938.78 | 2022-2025 | Opzelura, Opzelura |
| Sun Pharmaceutical Industries INC. | $693.13 | 2021-2025 | Ilumya |
| Pfizer INC. | $558.65 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $525.77 | 2023-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $461.45 | 2021-2025 | Nemluvio, Aklief |
| Ucb, INC. | $435.61 | 2021-2025 | Bimzelx, Cimzia |
| Dermavant Sciences, INC. | $422.70 | 2022-2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $420.83 | 2021-2025 | Dupixent |
| Genzyme Corporation | $379.03 | 2021-2025 | |
| Leo Pharma INC. | $364.03 | 2021-2025 | Adbry, Anzupgo, Spevigo |
| Novartis Pharmaceuticals Corporation | $296.79 | 2022-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $277.18 | 2021-2025 | Siliq, Cabtreo, Jublia |
| Organon LLC | $256.87 | 2025 | Vtama |
| Lilly USA, LLC | $241.89 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Janssen Scientific Affairs, LLC | $235.16 | 2022 | |
| Vyne Pharmaceuticals INC. | $131.13 | 2021 | |
| Almirall LLC | $125.29 | 2022-2024 | Klisyri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.03 | 2025 | Spevigo |
| Mayne Pharma Commercial LLC | $89.37 | 2021-2025 | |
| Allergan, INC. | $56.96 | 2021-2022 | |
| Journey Medical Corporation | $47.50 | 2023-2024 | |
| Botanix Sb INC | $21.49 | 2025 | Sofdra |
| Medtronic, INC. | $18.91 | 2022 | |
| Epi Health, LLC | $18.68 | 2021 | |
| Bard Peripheral Vascular, INC. | $15.35 | 2025 | Venclose Maven Catheter |
| Strata Skin Sciences, INC. | $12.99 | 2023 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Shaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.